ArticleEJHaem2026
Elranatamab for Treatment of Multiple Myeloma With Central Nervous Involvement Refractory to Other Interventions.
Kelley Julian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it